Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2014; 20(13): 3564-3571
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3564
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3564
Figure 1 Chemical structures of aminosalicylates and their colon-targeting prodrugs.
A: 5-ASA; B: Sulfasalazine; colon-targeting prodrug of 5-ASA with sulfapyridine; C: 4-ASA; D: Amide prodrug of 4-ASA with glycine; E: L-arginine salts of 4-ASA and 5-ASA; F: H2S-releasing prodrugs of 5-ASA and 4-ASA; G: Prodrugs of 4-ASA with salicylic acid, hydroxybenzene and N-salicyloyl glycine; H: Prodrugs of 4-ASA with substituted phenols; I: amide conjugate of 4-ASA with D-phenylalanine; J: Amide conjugate of 4-ASA with L-tryptophan; K: Amide prodrug of 4-ASA with D-glucosamine; L: Polymeric prodrug of 4-ASA; M: Prodrug of 4-ASA with 4-ASA (4A-4AAz).
- Citation: Dhaneshwar SS. Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease. World J Gastroenterol 2014; 20(13): 3564-3571
- URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3564.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i13.3564